We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Regeneron Pharmaceuticals Inc | NASDAQ:REGN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
-14.62 | -1.61% | 891.92 | 891.94 | 893.68 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
915.00 | 876.75 | 911.09 | 282,983 | 18:22:17 |
Date | Time | Source | Headline |
---|---|---|---|
16/11/2023 | 16:39 | DJN | Regeneron Currently Down Eight Consecutive Days, On Track for Longest.. |
15/11/2023 | 16:29 | DJN | Regeneron Pharmaceuticals Currently Down Seven Consecutive Days, on Track.. |
10/11/2023 | 15:00 | DJN | Bayer Gets CHMP Backing for Higher-Dose Eylea in Two Major Retinal Eye.. |
13/10/2023 | 16:57 | DJN | Regeneron Pharmaceuticals on Pace for Record High Close -- Data Talk |
29/9/2023 | 14:11 | DJN | Regeneron Gets FDA Priority Review of Odronextamab in Follicular, Diffuse.. |
25/9/2023 | 23:12 | DJN | Ultragenyx Says the Cholesterol Evkeeza Gets Canadian Approval |
08/9/2023 | 22:24 | DJN | Regeneron Finance Chief Robert Landry to Retire |
19/8/2023 | 00:39 | DJN | Regeneron Pharmaceuticals Gets FDA OK for High-Dose Eylea Eye Treatment |
18/8/2023 | 19:42 | DJN | Regeneron Pharmaceuticals' Veopoz Gets FDA Approval for Adults, Children |
09/8/2023 | 14:34 | DJN | Decibel Therapeutics Shares Surge on Regeneron Acquisition |
1 Year Regeneron Pharmaceuticals Chart |
Intraday Regeneron Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions